16:14 EDT Immatics files to sell 2.42M ordinary shares for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IMTX:
- Immatics Announces Second Quarter 2023 Financial Results and Business Update
- Immatics reports Q2 EPS (32c), consensus (27c)
- Immatics initiates Phase 1/2 trial to evaluate PRAME TCR bispecific IMA402
- Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors
- Immatics (NASDAQ:IMTX) Gains on Equity Infusion by Bristol-Myers Squibb (NYSE:BMY)